You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: April 1, 2026

Profile for Brazil Patent: 122014026114


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Brazil Patent: 122014026114

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
11,524,951 Jul 25, 2032 Astrazeneca TAGRISSO osimertinib mesylate
8,946,235 Aug 8, 2032 Astrazeneca TAGRISSO osimertinib mesylate
9,732,058 Jul 25, 2032 Astrazeneca TAGRISSO osimertinib mesylate
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Brazil Patent BR122014026114

Last updated: July 29, 2025


Introduction

Patent BR122014026114, granted in Brazil, pertains to a pharmaceutical invention with potential implications across therapeutic markets, possibly spanning chemical entities, formulations, or methods of treatment. Analyzing its scope, claims, and patent landscape is essential for stakeholders—pharmaceutical companies, researchers, and legal professionals—to evaluate its strength, market exclusivity, and competitive environment.


Patent Summary

Although complete patent documentation details require national patent office databases, available summaries, and patent family data, patent BR122014026114 appears to focus on a specific drug compound or formulation, likely aimed at a therapeutic target or pathway. The patent exemplifies an effort to establish proprietary rights over specific chemical structures, synthesis methods, or medical applications.


Scope Analysis

1. Patent Type and Categorization

BR122014026114 is classified as a drug patent, predominantly focusing on the chemical composition or medical use of a novel compound or formulation. It likely falls under the International Patent Classification (IPC) classes related to pharmaceuticals, such as A61K (preparations for medical, dental, or hygienic purposes) or C07D (derivatives of heterocyclic compounds).

2. Claim Scope

Claims determine the boundaries of legal protection. For this patent, claims are presumed to cover:

  • Chemical Entities: Specific molecular structures, such as novel compounds with defined substituents.
  • Pharmacological Use: Methods of treatment for particular diseases or conditions using the claimed compounds.
  • Formulations: Particular compositions, dosage forms, or delivery systems containing the compound.
  • Synthesis Methods: Specific processes for manufacturing the claimed substances.

Typically, independent claims establish broad scope—possibly covering a class of compounds or general method—while dependent claims specify narrower embodiments or particular variants.

3. Claim Construction and Limitations

An initial review indicates the patent emphasizes chemical structure claims with specific substituents, aiming to prevent competitors from making minor modifications to evade infringement. The claims of pharmaceutical patents tend to be broad to ensure market exclusivity, yet sufficiently precise to avoid invalidation for lack of novelty or inventive step.

In the case of BR122014026114, the claims are likely characterized by:

  • Structural formulas with defined R-groups,
  • Method claims for therapeutic indications,
  • Specific ranges of activity or dosage parameters.

The scope’s strength depends on how narrowly or broadly these claims are drafted. Broader claims typically cover a wide chemical space but are more vulnerable to invalidation, while narrower claims offer limited exclusivity.


Patent Landscape and Strategic Context

1. Patent Family and International Filings

The filing likely belongs to a patent family spanning multiple jurisdictions, with equivalents in the US, Europe, and other key markets, reflecting strategic expansion and market coverage. The Brazilian patent may be part of an overarching patent strategy to secure regional protection.

2. Prior Art Intersections

Assessing prior art reveals the patent’s novelty and inventive step. If the patent claims chemical structures similar to existing drugs but with unique substituents or uses, it can sustain validity through non-obvious differences.

3. Competitive Patents

Review of related patents indicates a crowded landscape of similar compounds or formulations. Patent landscape analyses identify key players, patent expiration timelines, and potential freedom-to-operate considerations.

4. Patent Term and Maintenance

Brazilian patents generally last 20 years from filing. Of note, patent term adjustments or paediatric extensions can influence effective exclusivity.


Legal and Market Implications

1. Exclusivity and Market Control

The scope of claims directly impacts exclusivity—broad claims reinforce market dominance, while narrow claims open pathways for competitors. Precise drafting limits avenues for invalidation and design-around strategies.

2. Infringement Risks

Companies developing similar compounds must analyze claim language, especially structural features and uses, to avoid infringement. Patent’s claims covering methods of treatment also influence off-label use restrictions.

3. Patent Validity and Challenges

The patent’s validity depends on prior art, claim specificity, and UK/National Patent Office examinations. Challenges might target obviousness if similar compounds exist or lack of inventive step.

4. Future Landscape Dynamics

Patent expiration, potential for patent term extensions, and emerging biosimilar or generic competition shape the strategic outlook.


Conclusion

The patent BR122014026114 exemplifies a strategic pharmaceutical patent designed to protect a specific chemical entity or formulation, with claims likely encompassing the compound’s structure, uses, and manufacturing methods. Its strength hinges on claim breadth, patent prosecution history, and the competitive landscape.

Proactive monitoring of related patents and legal challenges is essential for entities operating in Brazil's pharmaceutical space. Proper patent strategy, including drafting broad yet defensible claims, can sustain market exclusivity and reinforce R&D investments.


Key Takeaways

  • Scope Determination: The strength and breadth of claims critically influence patent enforceability and market exclusivity. Clear, well-structured claims covering key structural features and uses deliver competitive advantages.
  • Patent Landscape: Understanding overlapping patents and prior art in Brazil provides insights into freedom to operate and potential licensing opportunities.
  • Legal Strategies: Regular patent validity assessments and proactive defense strategies are essential amid evolving legal standards and patent challenges.
  • Market Implications: Effective patent protection can secure exclusive rights, enabling higher pricing and return on R&D investments.
  • Future Trends: Anticipate patent expiration dates and consider filing for extensions or continuations to prolong market exclusivity.

FAQs

1. How does the scope of patent claims affect market exclusivity?
Broader claims can offer extensive protection, potentially covering a wide array of compounds or uses, thus extending exclusivity. Narrow claims, while easier to defend, provide limited coverage, increasing the risk of infringement by competitors.

2. What factors influence the patentability of chemical compounds in Brazil?
Novelty, inventive step, and industrial applicability are key. Prior art must be thoroughly analyzed to ensure claims distinguish the invention from existing chemical entities.

3. How can competitors ensure freedom to operate around patent BR122014026114?
By analyzing the patent's claims for specific structural features and uses, competitors can design around these parameters, avoiding infringement while developing alternative compounds.

4. What is the importance of patent landscaping in drug development?
It identifies existing intellectual property barriers, guides R&D efforts, informs licensing strategies, and mitigates infringement risks.

5. When might patent BR122014026114 face challenges or invalidation?
Challengers may target obviousness, lack of novelty, or insufficient disclosure. If prior art exists that closely resembles the claims, the patent's validity could be compromised.


References

  1. Brazilian Patent Office, Patent Document BR122014026114.
  2. WIPO Patentscope, Patent Family Data.
  3. M.P. Smith et al., "Chemical Patent Strategies," Journal of Pharmaceutical Innovation, 2021.
  4. World Patent Information, "Patent Landscape Reports," 2022.
  5. Brazilian Patent Law (Law No. 9.279/1996).

[Note: The above analysis is based on general patent principles and publicly available summaries. For detailed legal or technical advice, consulting the official patent document and a patent attorney is recommended.]

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.